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Down syndrome (DS) is the most common chromosomal disorder 
in newborns, with a birth prevalence of approximately 2/1 000 
live births in South Africa (SA).[1,2] However, little is known about 
the epidemiological profile of this syndrome in KwaZulu-Natal 
Province (KZN). Before the 1980s DS was thought to be rare 
in black African population groups.[3] In 1982, Adeyokunnu[4] 
dispelled this myth in a retrospective study on the birth prevalence 
of DS in Ibadan, Nigeria, documenting a birth prevalence of 
1.16/1 000 live births.[4] It was not until the mid-1990s, when Venter 
et al.[5] documented a birth prevalence of 2.1/1 000 live births in 
rural Limpopo Province and Kromberg et al.[6] 1.8/1 000 live births 
at Chris Hani Baragwanath Hospital in Soweto, Johannesburg, that 
the high birth prevalence of DS was appreciated in SA. The high 
birth prevalence of DS in developing countries (2 - 3/1 000 live 
births) is attributed to the high proportion of pregnant woman who 
are of advanced maternal age (AMA).[2] However, little further work 
has been undertaken on DS in black African children in SA, and 
Christianson’s[3] concerns about lack of awareness and difficulty in 
diagnosing DS by medical staff still appear to pertain. He described 
difficulties in recognising DS in black African neonates and young 
children, resulting in delays in diagnosing DS in SA, where only 
16.4% of cases were diagnosed during the infant’s postnatal stay 
in the hospital or clinic.[3] The many abnormalities associated with 
DS make early diagnosis important in the care of children with 
the disorder.[7] Early detection of treatable disorders associated 
with DS, such as hypothyroidism, may prevent further irreversible 
mental and physical disabilities.[8] The high cost of medical care for 
patients affected with DS[1] also highlights the need for a largely 
preventive healthcare programme for these patients. Most of the 
improvements in quality of life for patients with DS are related 
to implementing early intervention programmes and improving 
support for parents. [7] Effective preventive care benefits from early 
diagnosis of the disorder.
Objectives
To establish an epidemiological profile of postnatal DS in KZN 
and highlight the issues that arise therefrom, including indicating 
the burden of this congenital disorder in the province. The age of 
cytogenetic diagnosis of DS and the ratio of clinically suspected to 
cytogenetically proven DS were used as an indication of the abilities 
of clinicians in the province to diagnose DS accurately.
Methods
The log books and electronic records at the South African National 
Blood Service (SANBS) cytogenetic laboratory in Pinetown, KZN, 
were perused for postnatal chromosomal blood tests for clinically 
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Background. Down syndrome (DS) is the most common chromosomal disorder in newborns. Until 20 years ago DS was considered rare 
in black African children in South Africa (SA). Lack of awareness of DS on the part of medical staff in SA, and difficulty in diagnosing it, 
appear to persist.
Objectives. To establish an epidemiological profile of DS and investigate the ability of clinicians in KwaZulu-Natal Province (KZN), SA, to 
make accurate clinical diagnoses of DS.
Methods. Records at the South African National Blood Service cytogenetic laboratory in Pinetown, KZN, were examined for all tests for 
clinically suspected DS undertaken during January 2009 - December 2013 and all cytogenetically proven DS test results. Age at diagnosis, 
the hospital from where the test was sent and type of chromosomal pattern for each confirmed DS test result were recorded.
Results. Of a total of 1 578 tests requested, 875 confirmed DS, indicating that clinicians correctly clinically diagnosed DS 55.4% of the time. 
The average age of cytogenetic diagnosis of DS was 1 year and 20 days. The minimum population prevalence of DS was 0.8/1 000.
Conclusions. The diagnosis of DS is a challenge in KZN, potentiating missed opportunities for early intervention. The relatively low 
population prevalence of DS may be attributable to a lack of confirmatory cytogenetic tests or missed clinical diagnoses. It may also be 
attributable to a high mortality rate for children with DS in the province.
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suspected and cytogenetically proven DS 
undertaken during the period January 2009 - 
December 2013.
The SANBS mainly serves the state sector 
in KZN and does all the medical genetic 
testing for DS for the state sector in the 
province. Blood samples are referred to the 
SANBS cytogenetic laboratory along with a 
document in which the referring clinician 
states the suspected disorder for which 
testing is being done. Data were collected 
onto an Excel spreadsheet. Age at diagnosis, 
hospital from which the blood sample was 
sent and the type of chromosomal pattern 
for each confirmed DS test result within 
the time period were recorded. To ensure 
anonymity, labelling of test results was 
resolved by number and patient’s names 
were not recorded. Duplicate test results, 
where found, were excluded. Ethics approval 
to conduct the study was obtained from 
the University of KwaZulu-Natal Biomedical 
Research Ethics Committee (Ref. No. BE 
431/14). Permission to use data from SANBS 
was granted before data collection began.
Results
From 1 January 2009 to 31 December 2013, 
blood samples from a total of 1 578 patients 
suspected of having DS were sent to the 
laboratory for chromosomal confirmation of 
the diagnosis. Of these analyses, 875 confirmed 
the diagnosis of DS cytogenetically. The num-
ber of live births recorded for the same 5-year 
period in KZN was 1 046 623. [9] This gives a 
minimum population prevalence of DS in the 
province of 0.8/1 000 (1/1 205). The ratio of 
suspected to cytogenetically proven DS was 
55.4% for this period. The number of tests for 
chromosomal confirmation of DS increased 
in each year of the study. However, the ratio 
of suspected to cytogenetically proven DS 
decreased over the same time period (Table 1).
During the study period, the number 
of negative tests when DS was clinically 
sus pected was 703. According to the 2009 - 
2013 SANBS tariffs for blood chromosomal 
analysis, the total cost of these tests 
amounted to ZAR1 174 734. Chromosomal 
diagnoses of DS were made at an average age 
of 1 year and 20 days over the 5-year period. 
Cytogenetic analyses revealed that 92.8% of 
the cases of DS were due to non-dysjunction, 
5.0% involved translocation of chromosome 
21, and 2.2% were mosaic. Mosaic DS was 
diagnosed on average at 1 year 9 months, 
whereas translocation DS was diagnosed at a 
much earlier average age of 5 months and 6 
days. Non-dysjunction DS was diagnosed at 
an average age of 1 year and 7 days (Table 2).
Fig. 1 illustrates the number of cyto-
genetically proven DS patients according 
to the healthcare facility category at which 
the initial diagnosis was made. Healthcare 
facilities were divided into specialist-driven 
facilities (academic/tertiary-level hospitals 
and regional/secondary-level hospitals) and 
non-specialist-driven facilities (district-level 
hospitals, primary healthcare hospitals and 
clinics). A very limited number of requests 
for DS diagnosis were received from private 
practice (private hospitals, private doctors’ 
rooms and private pharmacies). This is 
probably because private laboratories carried 
out the tests for the private sector. Of all the 
cytogenetically proven DS patients, 76.7% 
(n=671) were diagnosed in specialist-driven 
hospitals, which comprised 29.4% (n=15) 
of the healthcare facilities in KZN where 
initial diagnoses of DS were made. Non-
specialist hospitals and clinics constituted 
56.9% (n=29) of the healthcare facilities 
at which diagnoses were made, but only 
22.2% (n=194) of the total number of cyto-
genetically confirmed DS patients came 
from these sites. Private facilities constituted 
13.7% (n=7) of all the healthcare facilities 
where diagnoses were made, and only 1.1% 
(n=10) of cytogenetically confirmed DS 
patients came from those sources.
Fig. 2 illustrates the average age at which DS 
was cytogenetically confirmed according to 
the different healthcare facility categories. In 
specialist-driven facilities, 671 of DS patients 
(76.7%) were correctly clinically diagnosed, 
at the lowest average age of 11 months and 
15 days. In non-specialist-driven facilities, 
194 DS patients (22.2%) were diagnosed at a 
later average age of 1 year and 1 month. Only 
10 (1.1%) of DS patients were diagnosed in 
private facilities, at the latest average age of 
7 years and 6 months.
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Fig. 2. Average age at diagnosis of DS according to healthcare facility category.
Table 1. Ratios of clinically suspected DS to cytogenetically confirmed DS by year
Year
2009 2010 2011 2012 2013 Total
Suspected DS, n 230 280 355 321 392 1 578
Cytogenetically proven DS, n 154 171 203 169 178 875
Correctly clinically diagnosed DS, % 67.0 61.0 57.2 52.6 45.4 55.4
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Fig. 1. Number of cytogenetically proven DS patients according to healthcare facility category.
Table 2. Proportions of the different types of DS with average age at cytogenetic diagnosis
  Non-dysjunction Translocation Mosaic 
Proportion, % 92.8 5.0 2.2
Average age at diagnosis  1 yr 7 d 5 mo 6 d 1 yr 9 mo 14 d
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Discussion
DS is a common congenital disorder that until 20 years ago was 
considered rare in black Africans of SA origin.[3] At that time it was 
shown that doctors, nurses and mothers lacked awareness of DS 
in black infants, that the disorder was easier to recognise in white 
infants, and that awareness of DS in communities was limited owing 
to a high mortality rate among affected infants, resulting in a low 
population prevalence of DS.[3,10]
DS is the most common chromosomal disorder in liveborn 
infants, with no predilection for race or socioeconomic group. It 
is the most well-known and well-researched genetic disorder,[10] 
yet postnatal diagnosis in KZN, and in SA as a whole, remains a 
challenge. In KZN the average age at cytogenetic diagnosis of DS 
was 1 year and 20 days. In Gauteng and Limpopo provinces, more 
than half of the patients with DS attending a genetics clinic were 
diagnosed after 7 months of age.[3] The diagnosis of DS is largely a 
clinical one, based on characteristic dysmorphic features, and may 
be confirmed by chromosomal testing. It is possible that the age of 
chromosomal diagnosis in this study is not an absolute indication of 
the age of clinical diagnosis, as some patients may have been correctly 
diagnosed and managed without chromosomal confirmation, or 
cytogenetic testing may have been done at a later stage. This may be 
due to concerns about the financial cost of obtaining a cytogenetic 
diagnosis. However, in our study clinicians clinically suspected DS 
accurately only 55% of the time. This differs markedly from a study 
in The Netherlands, where clinicians correctly clinically diagnosed 
DS 83% of the time.[11] The average age of chromosomal diagnosis in 
that study was 1.8 days for infants born in hospital and 10.2 days for 
those born outside hospital.[11] We postulate that the late age at which 
some children with DS were diagnosed in the private sector was 
because some patients’ families did not receive the recognition and 
care that their children with DS deserved in public sector hospitals 
and therefore sought medical care elsewhere, resulting in delayed 
presentation to those facilities.
Diagnosis and prevention of DS with prenatal screening is not 
routinely and universally offered in public sector hospitals in SA. It 
is available in academic centres, but even in these, prenatal screening 
for DS using the most basic tool, a pregnant woman’s age, is poorly 
undertaken. In a study of 48 women of AMA seen in academic 
hospitals in Johannesburg and having presented for antenatal care 
before 20 weeks’ gestation, not one was offered counselling for 
prenatal diagnosis on the basis of her age.[12] Only 6.6 - 8.6% of 
confirmed DS patients were diagnosed antenatally in Cape Town, 
where public health services are among the best developed in 
SA.[13] The diagnosis of DS therefore remains almost entirely the 
responsibility of the healthcare workers who come into contact with 
these infants and children in the postnatal period. Congenital heart 
disease, which affects approximately half of all infants and children 
with DS,[11] along with malnutrition and infections, is a significant 
cause of mortality for children with DS in SA, particularly in the 
context of limited availability of facilities for cardiac surgery.[3] In 
our study, the minimum population prevalence of DS was 0.8/1 000 
over the 5-year period. This is more than two times lower than birth 
prevalences of DS that were prospectively obtained in other areas of 
the country (2.1/1 000 live births in rural Limpopo[4] and 1.8/1 000 
in Soweto, Johannesburg[5]). In part this may be due to the poor 
ability of SA medical practitioners and nurses to diagnose DS. It may 
also reflect a falsely low calculated population prevalence because of 
some patients not being confirmed with chromosomal analysis, as 
described earlier. However, given the late age of diagnosis and the 
apparent inability to recognise DS accurately in KZN, it is surely 
contributed to by a high mortality rate among children with DS in 
the province. In an epidemiological study of intellectually disabled 
children aged 2 - 9 years in a rural community in Mpumalanga 
Province, the minimum population prevalence of DS was 0.75/1 000 
and the authors calculated that two out of every three children with 
DS had died before the age of 2 years.[14] It may be that in SA many 
children with DS are undiagnosed at the time of their death and 
recorded in under-5 mortality rates under various classifications 
indicative of DS symptoms or complications (e.g. pneumonia), 
resulting in the impact of DS as a public health issue being largely 
unrecognised.
Conclusions
Despite the limitations in using age of chromosomal diagnosis as 
an indication of age of clinical diagnosis, it is evident that medical 
practitioners and nursing staff in KZN have difficulty in making 
accurate clinical diagnoses of DS, resulting in missed opportunities 
for early intervention. With the proportion of confirmed diagnoses 
being poor to start with and then declining over time, it seems 
that the ability to diagnose DS clinically is waning. The cost of 
these clinically inappropriate chromosomal tests is considerable. 
The relatively low population prevalence of DS seen in this study, 
compared with far higher prospectively obtained birth prevalences 
in other areas of SA, suggests that many children with DS may in 
fact die before they are diagnosed. It is apparent from this study that, 
20 years after showing that DS is a largely unrecognised problem in 
SA, little has changed, with potentially dire consequences for patients 
and their families. There is a great need to increase awareness of DS 
among medical and nursing staff and in communities, especially in 
hospitals and clinics that do not have specialist care and supervision. 
Our figures represent reliable data from the only cytogenetic service 
provider to the state sector in KZN. It is possible that similar studies 
in other provinces would reveal similar findings. In 2010 the World 
Health Organization’s World Health Assembly passed resolution 
WHA63.17, urging member states to recognise congenital disorders 
(CDs) as a public health issue. They proposed that CDs would 
contribute to a failure to attain Millennium Development Goal 4 
in low- and middle-income countries.[15] If diagnosis, which is the 
first step in the clinical pathway to care for people with DS, the 
best-known and most common chromosomal disorder, is as poor 
as described in this study, what are the implications for children 
with other less easily recognisable CDs in KZN and SA? Malherbe 
et al.[16] have recently suggested that the time is now optimal for the 
development of services for the care and prevention of congenital 
disorders in SA. The obvious place to start is with common 
disorders, especially DS.
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